Di-(2-ethylhexyl) phthalate accelerates atherosclerosis in apolipoprotein E-deficient mice
- 742 Downloads
Di-(2-ethylhexyl) phthalate (DEHP) is associated with atherosclerosis-related cardiovascular disease complications, but we lack direct evidence of its unfavorable effect on atherogenesis. In this study, we aimed to clarify in vivo and in vitro the contribution of DEHP to the development of atherosclerosis and its underlying mechanisms. Apolipoprotein E-deficient (apoE−/−) mice chronically treated with DEHP for 4 weeks showed exacerbated hyperlipidemia, systemic inflammation, and atherosclerosis. In addition, DEHP promoted low-density lipoprotein (LDL) oxidation, which led to inflammation in endothelial cells as evidenced by increased protein expression of pro-inflammatory mediators. Furthermore, chronic DEHP treatment increased hepatic cholesterol accumulation by downregulating the protein expression of key regulators in cholesterol clearance including LDL receptor, cholesterol 7α-hydrolase, ATP-binding cassette transporter G5 and G8, and liver X receptor α. Moreover, the adiposity and inflammation of white adipose tissues were promoted in DEHP-treated apoE−/− mice. In conclusion, DEHP may disturb cholesterol homeostasis and deregulate the inflammatory response, thus leading to accelerated atherosclerosis.
KeywordsDEHP Atherosclerosis Cholesterol metabolism Inflammation Obesity
The authors thank Laura Smales (BioMedEditing) for help in language editing.
Conflict of interest
The authors have declared no conflicts of interest.
- Cushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, Parhami F, Gerrity R, Schwartz CJ, Fogelman AM (1990) Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA 87:5134–5138PubMedPubMedCentralCrossRefGoogle Scholar
- Hao C, Cheng X, Guo J, Xia H, Ma X (2013) Perinatal exposure to diethyl-hexyl-phthalate induces obesity in mice. Front Biosci 5:725–733Google Scholar
- Sydor A, Drozdz M, Kraśniak A, Miłkowski A, Chmiel G, Małczak J, Zabawa-Hołyś S, Moskal K, Podwysocki A, Szmigielski M, Czarnecka D, Gozdecka H, Kowalczyk-Michałek M, Szczeklik A, Wiecek A, Sułowicz W (2002) Hyperhomocysteinemia and advancement of atherosclerosis in patients with chronic renal failure on maintenance hemodialysis. Przegl Lek 59:962–967PubMedGoogle Scholar
- Wouters K, van Gorp PJ, Bieghs V, Gijbels MJ, Duimel H, Lütjohann D, Kerksiek A, van Kruchten R, Maeda N, Staels B, van Bilsen M, Shiri-Sverdlov R, Hofker MH (2008) Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology 48:474–486PubMedCrossRefGoogle Scholar